90 related articles for article (PubMed ID: 26773402)
21. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
Breier C; Lisch HJ; Drexel H; Braunsteiner H
Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
[TBL] [Abstract][Full Text] [Related]
22. [Content of the main lipid components in blood serum lipoproteins of human and of various animal species].
Lizenko MV; Regerand TI; Bakhirev AM; Petrovskiĭ VI; Lizenko EI
Zh Evol Biokhim Fiziol; 2007; 43(2):155-61. PubMed ID: 17674708
[TBL] [Abstract][Full Text] [Related]
23. Distinct Fatty Acid Compositions of HDL Phospholipids Are Characteristic of Metabolic Syndrome and Premature Coronary Heart Disease-Family Study.
Paavola T; Bergmann U; Kuusisto S; Kakko S; Savolainen MJ; Salonurmi T
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066314
[TBL] [Abstract][Full Text] [Related]
24. High density lipoprotein changes during treatment of diabetic ketoacidosis.
Joven J; Rubiés-Prat J; de la Figuera M; Valdés M; Villabona CM; Chacón P; Masdeu S
Diabete Metab; 1985 Apr; 11(2):102-5. PubMed ID: 3924672
[TBL] [Abstract][Full Text] [Related]
25. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
Bulum T; Duvnjak L; Prkacin I
Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
[TBL] [Abstract][Full Text] [Related]
26. Parameters of high-density lipoproteins in patients with arterial hypertension in combination with other components of metabolic syndrome.
Ozerova IN; Perova NV; Shchel'tsyna NV; Mamedov MN
Bull Exp Biol Med; 2007 Mar; 143(3):320-2. PubMed ID: 18225752
[TBL] [Abstract][Full Text] [Related]
27. Non-high-density lipoprotein cholesterol changes in middle-aged obese men with and without metabolic syndrome during weight loss.
Kim M; Tanaka K
Metab Syndr Relat Disord; 2014 Nov; 12(9):464-71. PubMed ID: 25247924
[TBL] [Abstract][Full Text] [Related]
28. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia.
Tilly-Kiesi M; Tikkanen MJ
J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316
[TBL] [Abstract][Full Text] [Related]
29. High-density lipoprotein subclasses and their relationship to cardiovascular disease.
Superko HR; Pendyala L; Williams PT; Momary KM; King SB; Garrett BC
J Clin Lipidol; 2012; 6(6):496-523. PubMed ID: 23312047
[TBL] [Abstract][Full Text] [Related]
30. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
[TBL] [Abstract][Full Text] [Related]
31. Evidence of reduced plasma HDL subfractions in patients with cutaneous discoid lupus erythematosus.
Lagogianni I; Papapanagiotou A; Piperi C; Kalofoutis C; Troupis G; Zachari A; Kalofoutis A
Clin Biochem; 2005 Mar; 38(3):286-90. PubMed ID: 15708553
[TBL] [Abstract][Full Text] [Related]
32. [Various reasons for changes in the phospholipid composition of high density lipoproteins in hypoalphacholesterolemia].
Gerasimova EN; Nikitin IuP; Ozerova IN; Shcherbakova IA; Sidorenko BA
Vopr Med Khim; 1985; 31(3):132-6. PubMed ID: 4024525
[TBL] [Abstract][Full Text] [Related]
33. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities.
Kontush A; Therond P; Zerrad A; Couturier M; Négre-Salvayre A; de Souza JA; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1843-9. PubMed ID: 17569880
[TBL] [Abstract][Full Text] [Related]
34. Acute influence of smoking on plasma lipoproteins.
Gnasso A; Haberbosch W; Schettler G; Schmitz G; Augustin J
Klin Wochenschr; 1984; 62 Suppl 2():36-42. PubMed ID: 6482326
[TBL] [Abstract][Full Text] [Related]
35. Alterations of plasma glycerophospholipid and sphingolipid species in male alcohol-dependent patients.
Reichel M; Hönig S; Liebisch G; Lüth A; Kleuser B; Gulbins E; Schmitz G; Kornhuber J
Biochim Biophys Acta; 2015 Nov; 1851(11):1501-10. PubMed ID: 26291032
[TBL] [Abstract][Full Text] [Related]
36. Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins.
Hammad SM; Hunt KJ; Baker NL; Klein RL; Lopes-Virella MF
J Clin Lipidol; 2022; 16(2):173-183. PubMed ID: 35148982
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipids in HDL - Potential markers for adaptation to pregnancy?
Patanapirunhakit P; Karlsson H; Mulder M; Ljunggren S; Graham D; Freeman D
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158955. PubMed ID: 33933650
[TBL] [Abstract][Full Text] [Related]
38. Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults.
Rauschert S; Uhl O; Koletzko B; Mori TA; Beilin LJ; Oddy WH; Hellmuth C
Biol Sex Differ; 2017; 8():10. PubMed ID: 28360990
[TBL] [Abstract][Full Text] [Related]
39. Novel liquid chromatography-mass spectrometrymethod to analyze hdl lipidome.
Patol Fiziol Eksp Ter; 2016; 60(3):95-100. PubMed ID: 29244914
[TBL] [Abstract][Full Text] [Related]
40. Alterations of HDL particle phospholipid composition and role of inflammation in rheumatoid arthritis.
Giraud C; Tournadre A; Pereira B; Dutheil F; Soubrier M; Lhomme M; Kontush A; Sébédio JL; Capel F
J Physiol Biochem; 2019 Nov; 75(4):453-462. PubMed ID: 31392628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
